Medical/Pharmaceuticals

STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients inAustralia, New Zealand and throughout SE Asia. Under the ...

2019-10-14 14:00 136

Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business

Transaction Highlights: * Admedus has sold the distribution rights to its CardioCel® and VascuCel® product range for$A36.2 million (including all earnouts) to LeMaitre Vascular Inc. * $A22.8M upfront payment plus two instalments of $A1m each after 12 months and 36 months * Up to $A11.4M on...

2019-10-14 12:51 215

ZEISS showcases next-level eye care digitalization at AAO 2019

SAN FRANCISCO, Oct. 12, 2019 /PRNewswire/ -- At the Annual Meeting of the American Academy of Ophthalmology (AAO) inSan Francisco, ZEISS Medical Technology Segment will present the latest in digital eye care innovation and high-resolution imaging fromOctober 12 – 15, 2019. With the vision and the...

2019-10-12 22:00 511

CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership

* The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB * CMAB will provide full development and manufacturing services for BJ Bioscience's BJ-005 bi-functional antibody * BJ-005 is planned to ent...

2019-10-11 18:00 1244

Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.

SHANGHAI, Oct. 11, 2019 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that it has successfully completed a first-in-human phase I single ascending dose (SAD) clinical study of KPG-818 conducted inthe United States. This randomized, double-blind, placebo-controlled study evaluated the...

2019-10-11 13:00 266

Bayer G4A Partners With Wellthy Therapeutics

MUMBAI, India, Oct. 11, 2019 /PRNewswire/ -- Wellthy Therapeutics, South Asia's leading digital therapeutics (DTx) company today announced its partnership with Bayer (BAYN: DE) through its G4A partnership initiative. Wellthy Therapeutics stands out as onefrom over 750 digital health companies spr...

2019-10-11 09:00 620

WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules

SHANGHAI and CAMBRIDGE, Massachusetts and SANKT AUGUSTIN, Germany, Oct. 10, 2019 /PRNewswire/ -- WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual chemical space called GalaXi®. Largely built from WuXi AppTec's library of novel drug-like scaffolds, GalaXi® offers a...

2019-10-11 08:02 3067

Caliber Ophthalmics Introduces Sharpoint Edge CC3D Plus Product Line at AAO in San Francisco

WESTWOOD, Massachusetts, Oct. 10, 2019 /PRNewswire/ -- Caliber Ophthalmics, a division of Surgical Specialties Corporation (SSC), announced today the global launch of its Sharpoint™ Edge™ Clear Control 3D Plus line of phaco incision knives at the Annual Meeting of the American Academy of Ophthalm...

2019-10-10 22:09 476

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

YANTAI, China, Oct. 10, 2019 /PRNewswire/ -- Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan recognizesChina-based MabPlex International, Ltd (MabPlex) with the 2019 Global Growth Excellence Leadership Award. MabPle...

2019-10-10 21:00 407

Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors

SUZHOU, China and LONDON, Oct. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) and Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent's Ty...

2019-10-10 15:55 446

Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions

BENGALURU, India, Oct. 10, 2019 /PRNewswire/ -- Nearly 50% of patients with diabetes fail to get an annual eye examination done even in the US and EU. In many countries, less than 10% of patients referred to ophthalmologists by their primary-care physicians actually complete a dilated retinal exa...

2019-10-10 11:34 540

CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million

HONG KONG and NANJING, China, Oct. 9, 2019 /PRNewswire/ -- Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceu...

2019-10-09 20:58 451

BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for Its Genomics Data Platform

RIJSWIJK, Netherlands, Oct. 9, 2019 /PRNewswire/ -- BlueBee, a global bioinformatics solutions provider, has extended data operations to mainlandChina to serve genomic data processing needs in compliance with The Chinese Ministry of Health and Technology. This strategic move will serve existing a...

2019-10-09 20:00 359

Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial

LONDON, MUMBAI, India and BAYREUTH, Germany, Oct. 9, 2019 /PRNewswire/ -- - RESILIENT Protocol captures Encyclopedic information from tumors and uses Artificial Intelligence (AI) to optimize treatments; - Objective Response and Disease Control Comparable to or better than most Immunotherapy opti...

2019-10-09 17:56 741

World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots

In Its Sixth Year, the Global Campaign Highlights Ways to Reduce the Impact of a Condition that Contributes to One in Four Deaths Worldwide CHAPEL HILL, North Carolina, Oct. 9, 2019 /PRNewswire/ -- On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless ...

2019-10-09 12:00 303

Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd

* Experienced Pharmaceutical Executive * Decades of global business development, strategy and biologic drug development experience * Expertise to drive the next phase of AdAlta's growth MELBOURNE, Australia, Oct. 9, 2019 /PRNewswire/ -- The Board of AdAlta Limited (ASX:1AD), is pleased to a...

2019-10-09 09:42 475

Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy

PARIS, Oct. 9, 2019 /PRNewswire/ -- Analysis of the CANTO cohort published in the journalAnnals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to ...

2019-10-09 07:00 304

Osteopore wins top prize at Brands For Good 2019 for its contribution to patients

PERTH, Australia, Oct. 9, 2019 /PRNewswire/ -- Osteopore, a global bone regeneration technology provider has once again won top prizes atSingapore's prestigious Brands For Good awards ceremony. This year, Osteopore walked away with the Champion for Patent Improving Lives 2019 and Winner for Com...

2019-10-09 07:00 372

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

SHENZHEN, China, Oct. 8, 2019 /PRNewswire/ -- Chipscreen Biosciences Co., Ltd. (Chipscreen, Stock Symbol: 688321.SH) and Novogene Co., Ltd. (Novogene) recently announced a strategic partnership for companion diagnostics (CDx) development. Under the agreement, Novogene will develop a CDx for Chips...

2019-10-08 20:46 394

Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes Medicine

LEBANON, New Hampshire and MADRID, Oct. 8, 2019 /PRNewswire/ -- Precision Diabetes, LLC, an emerging leader in precision diabetes diagnostics, announced results today from two landmark diabetes studies on its predictive tests for kidney and cardiovascular complications of diabetes. These results ...

2019-10-08 20:30 360
12345 ... 348